FDA Extends Comment Period for Proposed Rulemaking on OTC Bronchodilator Drug Products

Summary

The FDA is extending the comment period for its proposed rulemaking to amend the monograph for over-the-counter bronchodilator drug products until September 27, 1995, in response to requests from interested persons to allow more time to assess and respond to the proposal.